These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 14770433)

  • 21. A comparison of three histological grading systems in endometrial cancer.
    Bilgin T; Ozuysal S; Ozan H
    Arch Gynecol Obstet; 2005 Jun; 272(1):23-5. PubMed ID: 15241614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas.
    Hachisuga T; Kawarabayashi T; Iwasaka T; Sugimori H; Kamura T; Tsuneyoshi M
    Gynecol Oncol; 1997 Apr; 65(1):115-20. PubMed ID: 9103400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
    Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
    Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
    Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
    Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK; Young RH; Scully RE
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of FIGO 1989 and 2009 recommendations on staging of endometrial carcinoma: pathologic analysis and cervical status in 123 consecutive cases.
    Korczynski J; Jesionek-Kupnicka D; Gottwald L; Piekarski J
    Int J Gynecol Pathol; 2011 Jul; 30(4):328-34. PubMed ID: 21623209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preoperative platelet count as index of the grading in endometrial carcinoma].
    Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
    Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study.
    McCluggage WG; Hirschowitz L; Wilson GE; Oliva E; Soslow RA; Zaino RJ
    Am J Surg Pathol; 2011 Feb; 35(2):289-94. PubMed ID: 21263250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.
    Scholten AN; Creutzberg CL; Noordijk EM; Smit VT
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1067-74. PubMed ID: 11958903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
    Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
    Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.